Femme Homme | 18 ans et plus
- | Pays :
- France
- | Organes :
- Sein
- | Spécialités :
- Thérapies Ciblées
- Hormonothérapie
Extrait
PARSIFAL - MedOPP067 - A randomized, multicenter, open-label, phase II trial to evaluate the efficacy and safety of palbociclib in combination with fulvestrant or letrozole in patients with HER2 negative, ER+ metastatic breast cancer.